The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.15
Bid: 8.80
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 0.70 (7.955%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.15
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

Mon, 14th Dec 2020 16:59

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and not separately reported by Alliance News:

----------

Tracsis PLC - Leeds-based provider of software, hardware and services for rail, traffic data and transport industries - Chief Financial Officer Max Cawthra sells 75,000 shares at 638.7p, worth GBP479,025, on Monday. Still has 93,022 shares, a 0.3% stake.

----------

Checkit PLC - Cambridge, England-based workflow management - Executive Chair Keith Daley buys 413,775 shares at 50.1 pence, worth GBP207,301, on Friday last week. Now holds 14.8 million shares, a 23.8% stake.

----------

London Stock Exchange Group PLC - trading and clearing operator and index calculator - Non-Executive Director Dominic Blakemore buys 928 shares at GBP86.21, worth GBP79,999, on Monday.

----------

Aquila Services Group PLC - London-based consultancy and support services in affordable housing, education, sports and community services sectors - Directors and associates buy 360,000 shares at 20p, worth GBP72,000, on Thursday last week. Chair Derek Joseph, Non-Executive Director Richard Wollenberg and Executive Director Fiona Underwood each buy 120,000 shares.

----------

Ocean Wilsons Holdings Ltd - Bermuda-based investment company operating a maritime services company in Brazil - Non-Executive Director Caroline Foulger buys 5,000 shares at 874p, worth GBP42,700, on December 4 and 7. Now interested in 10,000 shares.

----------

Spirax-Sarco Engineering PLC - Cheltenham, England-based thermal energy management and pumping - Non-Executive Director Caroline Johnstone buys 443 shares at 11,241.89p, worth GBP49,802, on Thursday last week.

----------

Audioboom Group PLC - London-based podcasts producer - Non-Executive Chair Michael Tobin buys 10,050 shares at 199p, worth GBP20,000, on Friday. Now has 280,616 shares, a 1.8% stake.

----------

Shield Therapeutics PLC - Newcastle, England-based pharmaceutical firm focussed on iron deficiency - Chief Executive Officer Tim Watts buys 100,000 shares at GBP0.70, worth GBP69,750, on Friday. Now has 548,700 shares.

----------

React Group PLC - South Derbyshire-based cleaning, hygiene and decontamination - Executive Chair Mark Braund buys 774,255 shares and CFO Andrea Pankhurst buys 463,458, both at 1.29p and together worth GBP15,966, on Friday. The shares are their only holdings. Braund was appointed at the start of this month and Pankhurst in May.

----------

SimplyBiz Group PLC - Zahid Bilgrami, CEO of Defaqto subsidiary, sells 55,000 shares at 180.00p, worth GBP99,000, on Friday. Still interested in 1.8 million shares. SimplyBiz bought Defaqto, a financial services technology firm with a platform that rates financial products and funds, for GBP74 million in March 2019.

----------

Churchill China PLC - Stoke-On-Trent, England-based ceramic products for hospitality and retail markets - CEO David O'Connor buys 4,850 shares at 1,340p, worth GBP64,990, while Finance Director David Taylor and Sales & Marketing Director James Roper each sell 2,000 shares at 1,272p, all on Friday. O'Connor now has 37,963 shares, while Taylor has 59,555. Roper has 1.0 million shares, a 9.1% stake.

----------

Scancell Holdings PLC - Oxford, England-based immunotherapies for treatment of cancer and infectious disease - Non-Executive Director Martin Diggle buys 248,823 shares via Vulpes Life Sciences Fund at 10.50p, worth about GBP26,126, on Friday. Vulpes now has 117.5 million shares, a 14.4% stake.

----------

JPMorgan China Growth & Income PLC - seeks total return from companies listed in Hong Kong, China and Taiwan - Non-Executive Director Alexandra Mackesy buys 1,600 shares at 641.78p, worth GBP10,268, on Friday last week.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
20 Nov 2019 10:01

Scancell To Receive New European Patent For Moditope Product

Scancell To Receive New European Patent For Moditope Product

Read more
23 Oct 2019 10:48

Scancell Hires Former Genkyotex Boss Ursula Ney As Non-Executive

Scancell Hires Former Genkyotex Boss Ursula Ney As Non-Executive

Read more
5 Sep 2019 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Friday 6 SeptemberMySale Group (re share placing)Berkeley GroupGreene 9 African Oil & 10 11 Design

Read more
4 Sep 2019 08:58

Scancell signs collaboration agreement with antibody technology company

(Sharecast News) - Cancer treatment developer Scancell has inked its first collaboration agreement with a "leading" antibody technology company for its new platform technology, AvidiMab.

Read more
20 Aug 2019 10:59

Scancell losses deepen as it presses on with development

(Sharecast News) - Novel immunotherapies developer Scancell Holdings reported a deeper operating loss in its final results on Tuesday, to £6.73m compared to £4.91m in the 2018 financial year.

Read more
20 Aug 2019 10:59

Scancell Annual Loss Widens Amid Product Pipeline Development

(Alliance News) - Immunotherapy firm Scancell Holdings PLC on Tuesday said its loss widened on higher development costs, while it is making strong progress on advancing its the 12 months to the of

Read more
19 Aug 2019 09:33

Scancell to begin SCIB1 UK trial as FDA issues linger in US

(Sharecast News) - Immunotherapy developer Scancell announced the initiation of and further updates to the 'SCIB1' phase 2 trial in patients with metastatic melanoma also receiving the checkpoint inhibitor 'pembrolizumab' (Keytruda) on Monday.

Read more
13 Aug 2019 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 14 August AvastHalf Year ResultsLookersHalf Year BeattyHalf Year Year

Read more
1 Jul 2019 14:42

Scancell Progresses Trials In "Busy And Productive" Six Months

(Alliance News) - Scancell Holdings PLC said on Monday it has been a "busy and productive" six months for the company.The company said that active patient recruitment for the two

Read more
18 Jun 2019 14:40

Scancell Appoints Vulpes Investment Management Co-Founder To Board

(Alliance News) - Scancell Holdings PLC on Tuesday said it has appointed Vulpes Investment Management Co-Founder & Portfolio Manager Martin Diggle to its board.Diggle joins the cancer a

Read more
13 Jun 2019 13:48

Scancell Shares Jump 30% As Vulpes Invests GBP4 Million (ALLISS)

(Alliance News) - Scancell Holdings PLC's shares soared Thursday as it received GBP3.9 million from a new investor.Scancell shares were up 31% in afternoon trade at a price of 7.00 Life

Read more
21 May 2019 13:25

N4 Pharma Appoints John Chiplin as Non-Executive Chairman

LONDON (Alliance News) - N4 Pharma PLC on Tuesday said it appointed John Chiplin as non-executive chair of the company with immediate effect.Furthermore, the pharmaceutical firm appointed a

Read more
20 May 2019 11:03

Scancell partnership with Cancer Research moves closer to clinic

(Sharecast News) - Immunotherapy developer Scancell Holdings updated the market on its clinical development partnership with Cancer Research UK for the development of the ;ImmunoBody' vaccine, SCIB2, as a potential treatment for patients with solid tumours, including non-small cell lung cancer (NSCLC), on Monday.

Read more
20 May 2019 11:02

Scancell Says Cancer Vaccine SCIB2 Will Be Given Using New Formulation

LONDON (Alliance News) - Scancell Holdings PLC said Monday cancer vaccine SCIB2 is to be administered using a new nanoparticle formulation in an early stage trial.Shares in Scancell were up

Read more
10 May 2019 10:49

Scancell Creates Advisory Board And Prepares For Drug Trials

LONDON (Alliance News) - Scancell Holdings PLC on Friday said it has established a clinical advisory board and has begun manufacturing and toxicity testing on its tumour drug in immunotherapy were

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.